Patient outcomes are making devices and services the core of the healthcare sector. This growing focus of companies to suffice patients’ growing expectations in terms of experience has solidified the infiltration of technology, with several leaps been made in the medical device sector over the last few decades. Innovation, such as laser technology, is revolutionizing the medical device industry in unique ways, while driving the sector ahead in a way that could deliver great dividends to healthcare providers and patients alike. Over the years, the medical application of light has evolved, with newer technologies and devices, such as photobiostimulation devices, which are capable of more precise parameters, taking center stage.
Photobiostimulation devices, prompted by the superfast success of laser- and light-based medical procedures, are garnering their share of the limelight, with healthcare providers drifting from invasive to non-invasive devices, in line with the growing demand for painless treatment. For medical companies, technology-driven devices such as photobiostimulation devices have not only taken their place as a powerful tool for uplifting service value, but have laid novel grounds for better customer interaction. Greater precision provided by photobiostimulation devices in wound care and pain management has been allowing clinicians to target specific light-absorbing molecules to treat select tissues. Acknowledging the significance of the photobiostimulation devices market, Transparency Market Research (TMR), in its latest study, lays bare the untapped potential in the marketplace for the foreseeable period of 2019–2027.
As the prevalence of chronic pain is unceasingly increasing, globally, photobiostimulation devices are set for sizeable recognition in the forthcoming years. Photobiostimulation devices with distinctive wavelength types, such as red light and infrared light, have made their place in assisting healthcare providers to prodigiously examine the core drivers of chronic pain or the primary mechanisms of wounds. This falls in line with a number of studies that suggest a narrow band of red and infrared light photobiostimulation devices as the clinical sweet-spot for health and safety.
Revenues from the market for photobiostimulation devices closed in on a valuation of over US$ 180 Mn in 2018. Global infiltration of photobiostimulation devices is envisaged to witness a colossal upshift through 2027, as technological penetration is picking up pace in the medical devices industry.
Advancements in the photobiostimulation devices market have picked up pace in recent years, thereby pushing the limits of product-feature development paradigms. One such growing trend in the photobiostimulation devices market is expanding applications by creating customized application-based variants. For instance, in view of the growing demand for painless-body contouring, photobiostimulation device manufacturers are focusing on developing variants specifically with a mid-600nm red light wavelength, in line with its ability to eliminate 99% contents of a cell within minutes. Non-invasive body contouring is currently the highest in-demand aesthetic treatment, caused by increased public awareness about its painless attribute and customers’ dire need to reduce unwanted body fat. Such new product development initiatives on the part of photobiostimulation devices market players are expected to make customized and bespoke devices no longer preserved solely for pain management or wound healing applications.
In view of the increased demand for convenience-driven personal therapeutic devices, the photobiostimulation devices market is witnessing an increased penetration of hand-held variants. Portable, lightweight, and rechargeable photobiostimulation devices for personal home therapy treatments are garnering traction as viable substitutes to the conventional variants. This is further likely to lay a robust base for the rapid adoption of photobiostimulation devices for home care applications.
The widening pain and other chronic illness patient pool, coupled with rising patient preference for painless, minimally-invasive therapies and treatments, continues to create opportunities for companies in the photobiostimulation devices market. Furthermore, continuing technological advancements in the medical devices sector are uplifting patient expectations for quicker and more effective therapies, thereby creating the demand for improved photobiostimulation devices.
Quicker Product Approval – Key Focus of Photobiostimulation Device Manufacturers
Stringent rules and regulations regarding photobiostimulation devices, a high risk new medical device, remain a key hurdle to market growth. The dire need to attain quicker product approval continues to hard press photobiostimulation device manufacturers to realign their core competencies into newer formats that are in compliance with the regulations in place. For instance, in July 2018, Erchonia Corporation announced the FDA 510(k) market approval for the FX 635 Laser for treating chronic low back pain of musculoskeletal origin. The FX 635 Laser is the only FDA-approved laser in the market for chronic neck and shoulder pain treatment. This remains the key differentiating strategy of established players, while most of the emerging players are wary of investing in the development of photobiostimulation devices at a steady pace, owing to their associated rigorous clinical trials prior to a premarket approval (PMA).
Promising Product Launches Hold a Competitive Advantage
Manufacturers in the photobiostimulation devices market are striving to relentlessly innovate their products with highly attributed features to remain pertinent in the rapidly-evolving competitive domain. Significant investments in R&D will continue to remain a vital cornerstone for photobiostimulation devices market players that are eying the expansion of therapeutic use of low-level laser devices (LLLT) as a treatment for neurodegenerative disorders. From a clinical standpoint, photobiostimulation devices make a readily-available and effective therapeutic tool that starts to address the gap in the therapeutic management of traumatic brain injury (TBI) and post-concussion syndrome injuries. For the fact that photobiostimulation is usually employed initially in the acute phase treatment, even before the full extent of the injury is known, photobiostimulation device manufacturers are eying the exploration of the potential of these devices for deeper level neurodegenerative disorder treatment.
The degree of competition remains moderate in the photobiostimulation devices market, due to the presence of only a few slightly-leading and more equally-sized players. The photobiostimulation devices market is witnessing the increased penetration of large pharmaceutical drug providers, which could increase the level of competition in the market in the coming years. The acquisition of the product profiles and R&D units of emerging players is a key strategy being adopted by frontrunners in the photobiostimulation devices market, who are aiming to co-develop innovative technologies. Strategic collaborations aimed at improved product development are likely to become a norm for photobiostimulation devices market players to gain a strong position in the industry. For instance, in November 2018, Erchonia Corporation, a leading player in the photobiostimulation devices market, entered into a partnership with InnerScope Hearing Technologies, and announced the development of Erchonia 3LT lasers for the treatment of hearing disorders.
Companies eying an established position in the photobiostimulation devices market are squeezing profit margins by reducing device prices, which is likely to remain a key strategy to form a strong base of customers. Sensing colossal growth potential of the photobiostimulation devices market in emerging countries, such as China and India, partakers are diligently working towards expanding their customer base by developing customized variants.
Analyst Viewpoint of the Photobiostimulation Devices Market
Photobiostimulation devices that use red to near-infrared light energy have garnered notable traction in recent years as a novel scientific approach with therapeutic applications, such as wound healing, joint pain relief, stroke recovery, nerve regeneration, and prevention and treatment of mucositis. As laser-based technologies and devices continue to become a common and safe modality to treat a range of conditions and health issues, the future could favor the accelerating growth of the photobiostimulation devices market.
Report analysts opine that, the photobiostimulation devices market is likely to scale new highs by the end of the foreseeable timeframe, with its value likely to surpass US$ 300 Mn by 2027. However, partakers still need to make efforts in terms of product innovation and cost-effectiveness to gain and maintain a strong hold in the photobiostimulation devices market.
This report analyzes the current and future condition of the global photobiostimulation devices market. Photobiostimulation devices are also known as low-level laser devices (LLLT). Photobiostimulation devices are used to reduce inflammation, edema, and pain; stimulate the healing of wounds, nerves, and deeper tissues, and avoid tissue impairment. Recent photobiostimulation devices use light emitting diodes (LEDs) to produce light of the essential wavelength to achieve particular results. Increase in technological advancements have revolutionized the use of photobiostimulation devices for pain management, wound care, and cosmetic applications. Photobiostimulation is being practiced across hospitals and clinics, globally.
Global Photobiostimulation Devices Market: Key Segments
Global Photobiostimulation Devices Market: Regional Outlook
Companies Mentioned in Photobiostimulation Devices Market Report
Photobiostimulation devices market to reach a market value exceeding US$ 300 Mn by 2027
Photobiostimulation devices market to expand at a CAGR of more than 6% from 2019 to 2027
Photobiostimulation devices market is driven by increase in number of patients with chronic pain and other chronic illnesses
North America accounted for a major share of the global photobiostimulation devices market
Key players in the global photobiostimulation devices market include Thor Photomedicine Ltd., Bioflex Laser Therapy, Ingeneus Pty. Ltd., Biolight Technologies, TheraDome, Inc.
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
3.1. Global Photobiostimulation Devices Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027
3.2. Global Photobiostimulation Devices Market: Market Snapshot
4. Market Overview
4.1. Global Photobiostimulation Devices Market: Wavelength Type Overview
4.2. Global Photobiostimulation Devices Market: Key Industry Developments
4.3. Market Dynamics
4.4. Drivers and Restraints Snapshot Analysis
4.5. Drivers
4.5.1. Increase in patient pool of chronic pain and other chronic illnesses
4.5.2. Rapidly increasing geriatric population
4.6. Restraints
4.6.1. Stringent FDA and CE approval norms
4.6.2. Limited adoption of photobiostimulation devices
4.7. Opportunities
4.8. Global Photobiostimulation Devices Market Revenue Projections (US$ Mn), 2017–2027
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario, by Region/globally
6. Global Photobiostimulation Devices Market Analysis, by Wavelength Type
6.1. Introduction
6.2. Global Photobiostimulation Devices Market Size and Forecast, by Wavelength Type
6.2.1. Infrared Light
6.2.2. Red Light
6.2.3. Others
6.3. Global Photobiostimulation Devices Market Analysis, by Wavelength Type
6.4. Global Photobiostimulation Devices Market Attractiveness Analysis, by Wavelength Type
7. Global Photobiostimulation Devices Market Analysis, by Application
7.1. Introduction
7.2. Global Photobiostimulation Devices Market Size and Forecast, by Application
7.2.1. Pain Management
7.2.2. Wound Care
7.2.3. Cosmetic Applications
7.2.4. Others
7.3. Global Photobiostimulation Devices Market Analysis, by Application
7.4. Global Photobiostimulation Devices Market Attractiveness Analysis, by Application
8. Global Photobiostimulation Devices Market Analysis, by End-user
8.1. Introduction
8.2. Global Photobiostimulation Devices Market Size and Forecast, by End-user
8.2.1. Specialty Clinics
8.2.2. Research Institutions
8.2.3. Home Care
8.2.4. Others
8.3. Global Photobiostimulation Devices Market Analysis, by End-user
8.4. Global Photobiostimulation Devices Market Attractiveness Analysis, by End-user
9. Global Photobiostimulation Devices Market Analysis, by Region
9.1. Global Photobiostimulation Devices Market Size and Forecast, by Region, 2017–2027
9.1.1. North America
9.1.2. Europe
9.1.3. Asia Pacific
9.1.4. Latin America
9.1.5. Middle East & Africa
9.2. Global Photobiostimulation Devices Market Analysis, by Region
9.3. Global Photobiostimulation Devices Market Attractiveness Analysis, by Region
10. North America Photobiostimulation Devices Market Analysis
10.1. North America Photobiostimulation Devices Market
10.2. North America Photobiostimulation Devices Market Overview
10.3. North America Photobiostimulation Devices Market Size and Forecast, by Wavelength Type
10.3.1. Infrared Light
10.3.2. Red Light
10.3.3. Others
10.4. North America Photobiostimulation Devices Market Size and Forecast, by Application
10.4.1. Pain Management
10.4.2. Wound Care
10.4.3. Cosmetic Applications
10.4.4. Others
10.5. North America Photobiostimulation Devices Market Size and Forecast, by End-user
10.5.1. Specialty Clinics
10.5.2. Research Institutions
10.5.3. Home Care
10.5.4. Others
10.6. North America Photobiostimulation Devices Market Forecast, by Country
10.6.1. U.S.
10.6.2. Canada
10.7. North America Photobiostimulation Devices Market Attractiveness Analysis
10.7.1. By Wavelength Type
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe Photobiostimulation Devices Market Analysis
11.1. Europe Photobiostimulation Devices Market
11.2. Europe Photobiostimulation Devices Market Overview
11.3. Europe Photobiostimulation Devices Market Size and Forecast, by Wavelength Type
11.3.1. Infrared Light
11.3.2. Red Light
11.3.3. Others
11.4. Europe Photobiostimulation Devices Market Size and Forecast, by Application
11.4.1. Pain Management
11.4.2. Wound Care
11.4.3. Cosmetic Applications
11.4.4. Others
11.5. Europe Photobiostimulation Devices Market Size and Forecast, by End-user
11.5.1. Specialty Clinics
11.5.2. Research Institutions
11.5.3. Home Care
11.5.4. Others
11.6. Europe Photobiostimulation Devices Market Forecast, by Country/Sub-region
11.6.1. U.K.
11.6.2. France
11.6.3. Germany
11.6.4. Spain
11.6.5. Italy
11.6.6. Rest of Europe
11.7. Europe Photobiostimulation Devices Market Attractiveness Analysis
11.7.1. By Wavelength Type
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Photobiostimulation Devices Market Analysis
12.1. Asia Pacific Photobiostimulation Devices Market Key Findings
12.2. Asia Pacific Photobiostimulation Devices Market Overview
12.3. Asia Pacific Photobiostimulation Devices Market Size and Forecast, by Wavelength Type
12.3.1. Infrared Light
12.3.2. Red Light
12.3.3. Others
12.4. Asia Pacific Photobiostimulation Devices Market Size and Forecast, by Application
12.4.1. Pain Management
12.4.2. Wound Care
12.4.3. Cosmetic Applications
12.4.4. Others
12.5. Asia Pacific Photobiostimulation Devices Market Size and Forecast, by End-user
12.5.1. Specialty Clinics
12.5.2. Research Institutions
12.5.3. Home Care
12.5.4. Others
12.6. Asia Pacific Photobiostimulation Devices Market Forecast, by Country/Sub-region
12.6.1. China
12.6.2. India
12.6.3. Japan
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Asia Pacific Photobiostimulation Devices Market Attractiveness Analysis
12.7.1. By Wavelength Type
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Photobiostimulation Devices Market Analysis
13.1. Latin America Photobiostimulation Devices Market Key Findings
13.2. Latin America Photobiostimulation Devices Market Overview
13.3. Latin America Photobiostimulation Devices Market Size and Forecast, by Wavelength Type
13.3.1. Infrared Light
13.3.2. Red Light
13.3.3. Others
13.4. Latin America Photobiostimulation Devices Market Size and Forecast, by Application
13.4.1. Pain Management
13.4.2. Wound Care
13.4.3. Cosmetic Applications
13.4.4. Others
13.5. Latin America Photobiostimulation Devices Market Size and Forecast, by End-user
13.5.1. Specialty Clinics
13.5.2. Research Institutions
13.5.3. Home Care
13.5.4. Others
13.6. Latin America Photobiostimulation Devices Market Forecast, by Country/Sub-region
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Latin America Photobiostimulation Devices Market Attractiveness Analysis
13.7.1. By Wavelength Type
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Photobiostimulation Devices Market Analysis
14.1. Middle East & Africa Photobiostimulation Devices Market
14.2. Middle East & Africa Photobiostimulation Devices Market Overview
14.3. Middle East & Africa Photobiostimulation Devices Market Size and Forecast, by Wavelength Type
14.3.1. Infrared Light
14.3.2. Red Light
14.3.3. Others
14.4. Middle East & Africa Photobiostimulation Devices Market Size and Forecast, by Application
14.4.1. Pain Management
14.4.2. Wound Care
14.4.3. Cosmetic Applications
14.4.4. Others
14.5. Middle East & Africa Photobiostimulation Devices Market Size and Forecast, by End-user
14.5.1. Specialty Clinics
14.5.2. Research Institutions
14.5.3. Home Care
14.5.4. Others
14.6. Middle East & Africa Photobiostimulation Devices Market Forecast, by Country/Sub-region
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Middle East & Africa Photobiostimulation Devices Market Attractiveness Analysis
14.7.1. By Wavelength Type
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Company Profiles
15.1.1. Thor Photomedicine Ltd.
15.1.1.1. Overview (HQ, Employee Strength, Business Segments)
15.1.1.2. Recent Developments
15.1.1.3. Strategy
15.1.2. Bioflex Laser Therapy
15.1.2.1. Overview (HQ, Employee Strength, Business Segments)
15.1.2.2. Recent Developments
15.1.2.3. Strategy
15.1.3. Ingeneus Pty. Ltd.
15.1.3.1. Overview (HQ, Employee Strength, Business Segments)
15.1.3.2. Recent Developments
15.1.3.3. Strategy
15.1.4. Biolight Technologies
15.1.4.1. Overview (HQ, Employee Strength, Business Segments)
15.1.4.2. Recent Developments
15.1.4.3. Strategy
15.1.5. TheraDome, Inc.
15.1.5.1. Overview (HQ, Employee Strength, Business Segments)
15.1.5.2. Recent Developments
15.1.5.3. Strategy
15.1.6. BioCare Systems, Inc.
15.1.6.1. Overview (HQ, Employee Strength, Business Segments)
15.1.6.2. Recent Developments
15.1.6.3. Strategy
15.1.7. Erchonia Corporation
15.1.7.1. Overview (HQ, Employee Strength, Business Segments)
15.1.7.2. Recent Developments
15.1.7.3. Strategy
15.1.8. Theralase Technologies, Inc.
15.1.8.1. Overview (HQ, Employee Strength, Business Segments)
15.1.8.2. Financials
15.1.8.3. Recent Developments
15.1.8.4. Strategy
List of Tables
TABLE 1 Key Industry Developments
TABLE 2 Regulatory Scenario: U.S. Food and Drug Administration (FDA)
TABLE 3 U.S. FDA Medical Devices Approval Criteria
TABLE 4 Regulatory Scenario: CE Market Approval/Classification
TABLE 5 European Approval for Medical Devices - Regulatory Pathway (Class IIb Devices only)
TABLE 6 Regulatory Scenario CFDA Approval Overview
TABLE 7 Global Photobiostimulation Devices Market Size (US$ Mn) Forecast, by Wavelength Type, 2017–2027
TABLE 8 Global Photobiostimulation Devices Market Size (US$ Mn) Forecast, by Application, 2017–2027
TABLE 9 Global Photobiostimulation Devices Market Size (US$ Mn) Forecast, by End-user, 2017–2027
TABLE 10 Global Photobiostimulation Devices Market Size (US$ Mn) Forecast, by Region, 2017–2027
TABLE 11 North America Photobiostimulation Devices Market Size (US$ Mn) Forecast, by Country, 2017–2027
TABLE 12 Table 12: North America Photobiostimulation Devices Market Size (US$ Mn) Forecast, by Wavelength Type, 2017–2027
TABLE 13 North America Photobiostimulation Devices Market Size (US$ Mn) Forecast, by Application, 2017–2027
TABLE 14 North America Photobiostimulation Devices Market Size (US$ Mn) Forecast, by End-user, 2017–2027
TABLE 15 Europe Photobiostimulation Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
TABLE 16 Europe Photobiostimulation Devices Market Size (US$ Mn) Forecast, by Wavelength Type, 2017–2027
TABLE 17 Europe Photobiostimulation Devices Market Size (US$ Mn) Forecast, by Application, 2017–2027
TABLE 18 Europe Photobiostimulation Devices Market Size (US$ Mn) Forecast, by End-user, 2017–2027
TABLE 19 Asia Photobiostimulation Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
TABLE 20 Asia Pacific Photobiostimulation Devices Market Size (US$ Mn) Forecast, by Wavelength Type, 2017–2027
TABLE 21 Asia Pacific Photobiostimulation Devices Market Size (US$ Mn) Forecast, by Application, 2017–2027
TABLE 22 Asia Pacific Photobiostimulation Devices Market Size (US$ Mn) Forecast, by End-user, 2017–2027
TABLE 23 Latin America Photobiostimulation Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
TABLE 24 Latin America Photobiostimulation Devices Market Size (US$ Mn) Forecast, by Wavelength Type, 2017–2027
TABLE 25 Latin America Photobiostimulation Devices Market Size (US$ Mn) Forecast, by Application, 2017–2027
TABLE 26 Latin America Photobiostimulation Devices Market Size (US$ Mn) Forecast, by End-user, 2017–2027
TABLE 27 Middle East & Africa Photobiostimulation Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
TABLE 28 Middle East & Africa Photobiostimulation Devices Market Size (US$ Mn) Forecast, by Wavelength Type, 2017–2027
TABLE 29 Middle East & Africa Photobiostimulation Devices Market Size (US$ Mn) Forecast, by Application, 2017–2027
TABLE 30 Middle East & Africa Photobiostimulation Devices Market Size (US$ Mn) Forecast, by End-user, 2017–2027
TABLE 31 Overview of Other Prominent Players
List of Figures
FIG. 1 Global photobiostimulation devices Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027
FIG. 2 Global Photobiostimulation Devices Market Revenue Projection (US$ Mn), 2017–2027
FIG. 3 Global Photobiostimulation Devices Market Value Share, by Wavelength Type, 2018
FIG. 4 Global Photobiostimulation Devices Market Value Share, by Application, 2018
FIG. 5 Global Photobiostimulation Devices Market Value Share, by Region, 2018
FIG. 6 Global Photobiostimulation Devices Market Value Share, by End-user, 2018
FIG. 7 Global Photobiostimulation Devices Market Value Share Analysis, by Wavelength Type, 2018 and 2027
FIG. 8 Global Photobiostimulation Devices Market Revenue (US$ Mn), by Infrared Light, 2017–2027
FIG. 9 Global Photobiostimulation Devices Market Revenue (US$ Mn), by Red Light, 2017–2027
FIG. 10 Global Photobiostimulation Devices Market Revenue (US$ Mn), by Others, 2017–2027
FIG. 11 Global Photobiostimulation Devices Market Attractiveness Analysis, by Wavelength Type, 2019–2027
FIG. 12 Global Photobiostimulation Devices Market Value Share Analysis, by Application, 2018 and 2027
FIG. 13 Global Photobiostimulation Devices Market Revenue (US$ Mn), by Pain Management, 2017–2027
FIG. 14 Global Photobiostimulation Devices Market Revenue (US$ Mn), by Wound Care, 2017–2027
FIG. 15 Global Photobiostimulation Devices Market Revenue (US$ Mn), by Cosmetic Applications, 2017–2027
FIG. 16 Global Photobiostimulation Devices Market Revenue (US$ Mn), by Others, 2017–2027
FIG. 17 Global Photobiostimulation Devices Market Attractiveness Analysis, by Application, 2019–2027
FIG. 18 Global Photobiostimulation Devices Market Value Share Analysis, by End-user, 2018 and 2027
FIG. 19 Global Photobiostimulation Devices Market Revenue (US$ Mn), by Specialty Clinics, 2017–2027
FIG. 20 Global Photobiostimulation Devices Market Revenue (US$ Mn), by Research Institutions, 2017–2027
FIG. 21 Global Photobiostimulation Devices Market Revenue (US$ Mn), by Home Care, 2017–2027
FIG. 22 Global Photobiostimulation Devices Market Revenue (US$ Mn), by Others, 2017–2027
FIG. 23 Global Photobiostimulation Devices Market Attractiveness Analysis, by End-user 2019–2027
FIG. 24 Global Photobiostimulation Devices Market Value Share, by Region, 2018 and 2027
FIG. 25 Global Photobiostimulation Devices Market Attractiveness, by Region, 2019–2027
FIG. 26 North America Photobiostimulation Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
FIG. 27 North America Photobiostimulation Devices Market Value Share Analysis, by Country, 2018 and 2027
FIG. 28 North America Photobiostimulation Devices Market Attractiveness, by Country, 2019–2027
FIG. 29 North America Photobiostimulation Devices Market Value Share Analysis, by Wavelength Type, 2018 and 2027
FIG. 30 North America Photobiostimulation Devices Market Attractiveness, by Wavelength Type, 2019–2027
FIG. 31 North America Photobiostimulation Devices Market Value Share Analysis, by Application, 2018 and 2027
FIG. 32 North America Photobiostimulation Devices Market Attractiveness, by Application, 2019–2027
FIG. 33 North America Photobiostimulation Devices Market Value Share Analysis, by End-user, 2018 and 2027
FIG. 34 North America Photobiostimulation Devices Market Attractiveness, by End-user, 2019–2027
FIG. 35 Europe Photobiostimulation Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
FIG. 36 Europe Photobiostimulation Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
FIG. 37 Europe Photobiostimulation Devices Market Attractiveness, by Country/Sub-region, 2019–2027
FIG. 38 Europe Photobiostimulation Devices Market Value Share Analysis, by Wavelength Type, 2018 and 2027
FIG. 39 Europe Photobiostimulation Devices Market Attractiveness, by Wavelength Type, 2019–2027
FIG. 40 Europe Photobiostimulation Devices Market Value Share Analysis, by Application, 2018 and 2027
FIG. 41 Europe Photobiostimulation Devices Market Attractiveness, by Application, 2019–2027
FIG. 42 Europe Photobiostimulation Devices Market Value Share Analysis, by End-user, 2018 and 2027
FIG. 43 Europe Photobiostimulation Devices Market Attractiveness, by End-user, 2019–2027
FIG. 44 Asia Pacific Photobiostimulation Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
FIG. 45 Asia Pacific Photobiostimulation Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
FIG. 46 Asia Pacific Photobiostimulation Devices Market Attractiveness, by Country/Sub-region, 2019–2027
FIG. 47 Asia Pacific Photobiostimulation Devices Market Value Share Analysis, by Wavelength Type, 2018 and 2027
FIG. 48 Asia Pacific Photobiostimulation Devices Market Attractiveness, by Wavelength Type, 2019–2027
FIG. 49 Asia Pacific Photobiostimulation Devices Market Value Share Analysis, by Application, 2018 and 2027
FIG. 50 Asia Pacific Photobiostimulation Devices Market Attractiveness, by Application, 2019–2027
FIG. 51 Asia Pacific Photobiostimulation Devices Market Value Share Analysis, by End-user, 2018 and 2027
FIG. 52 Asia Pacific Photobiostimulation Devices Market Attractiveness, by End-user, 2019–2027
FIG. 53 Latin America Photobiostimulation Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
FIG. 54 Latin America Photobiostimulation Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
FIG. 55 Latin America Photobiostimulation Devices Market Attractiveness, by Country/Sub-region, 2019–2027
FIG. 56 Latin America Photobiostimulation Devices Market Value Share Analysis, by Wavelength Type, 2018 and 2027
FIG. 57 Figure 57: Latin America Photobiostimulation Devices Market Attractiveness, by Wavelength Type, 2019–2027
FIG. 58 Latin America Photobiostimulation Devices Market Value Share Analysis, by Application, 2018 and 2027
FIG. 59 Latin America Photobiostimulation Devices Market Attractiveness, by Application, 2019–2027
FIG. 60 Latin America Photobiostimulation Devices Market Value Share Analysis, by End-user, 2018 and 2027
FIG. 61 Latin America Photobiostimulation Devices Market Attractiveness, by End-user, 2019–2027
FIG. 62 Middle East & Africa Photobiostimulation Devices Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
FIG. 63 Middle East & Africa Photobiostimulation Devices Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
FIG. 64 Middle East & Africa Photobiostimulation Devices Market Attractiveness, by Country/Sub-region, 2019–2027
FIG. 65 Middle East & Africa Photobiostimulation Devices Market Value Share Analysis, by Wavelength Type, 2018 and 2027
FIG. 66 Middle East & Africa Photobiostimulation Devices Market Attractiveness, by Wavelength Type, 2019–2027
FIG. 67 Middle East & Africa Photobiostimulation Devices Market Value Share Analysis, by Application, 2018 and 2027
FIG. 68 Middle East & Africa Photobiostimulation Devices Market Attractiveness, by Application, 2019–2027
FIG. 69 Middle East & Africa Photobiostimulation Devices Market Value Share Analysis, by End-user, 2018 and 2027
FIG. 70 Middle East & Africa Photobiostimulation Devices Market Attractiveness, by End-user, 2019–2027
FIG. 71 Theralase Technologies Inc. Revenue (US$) and Y-o-Y Growth (%), 2015–2017
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Photobiostimulation Devices Market
